Friday, 21 September 2012

Progenics Pharmaceuticals to reduce 26 percent of its workforce

(Reuters) - Biopharmaceutical company Progenics Pharmaceuticals Inc said it reduced its workforce by 26 percent to focus on mid-stage studies of its experimental prostrate cancer drug. As part of the restructuring, Chief Financial Officer Robert M...

Source: http://health.yahoo.net/news/s/nm/progenics-pharmaceuticals-to-reduce-26-percent-of-its-workforce

Jorja Fox history Facebook funny

No comments:

Post a Comment

Note: only a member of this blog may post a comment.